Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review. [electronic resource]
Producer: 20170502Description: 2403-2408 p. digitalISSN:- 1531-5053
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- epidemiology
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- drug therapy
- Diphosphonates -- adverse effects
- Femoral Fractures -- chemically induced
- Fractures, Spontaneous -- chemically induced
- Humans
- Injections, Intravenous
- Prevalence
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.